Inflammatory Cell Migration in Rheumatoid Arthritis: A Comprehensive Review.
Inflammatory Cell Migration in Rheumatoid Arthritis: A Comprehensive Review.
复制标题
类风湿关节炎中的炎症细胞迁移:全面评论。
DOI:
10.1007/s12016-015-8520-9
复制
发表时间:
2016-08
影响因子:
9.1
通讯作者:
Pereira JP
中科院分区:
文献类型:
--
作者:
Nevius E;Gomes AC;Pereira JP
Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disease that primarily affects the joints. Self-reactive B and T lymphocytes cooperate to promote antibody responses against self proteins and are major drivers of disease. T lymphocytes also promote RA independently of B lymphocytes mainly through the production of key inflammatory cytokines, such as IL-17, that promote pathology. While the innate signals that initiate self-reactive adaptive immune responses are poorly understood, the disease is predominantly caused by inflammatory cellular infiltration and accumulation in articular tissues, and by bone erosions driven by bone-resorbing osteoclasts. Osteoclasts are giant multinucleated cells formed by the fusion of multiple myeloid cells that require short-range signals, such as the cytokines MCSF and RANKL, for undergoing differentiation. The recruitment and positioning of osteoclast precursors to sites of osteoclast differentiation by chemoattractants is an important point of control for osteoclastogenesis and bone resorption. Recently, the GPCR EBI2 and its oxysterol ligand 7a, 25 dihydroxycholesterol were identified as important regulators of osteoclast precursor positioning in proximity to bone surfaces, and of osteoclast differentiation under homeostasis. In chronic inflammatory diseases like RA, osteoclast differentiation is also driven by inflammatory cytokines such as TNFa and IL-1, and can occur independently of RANKL. Finally, there is growing evidence that the chemotactic signals guiding osteoclast precursors to inflamed articular sites contribute to disease and are of great interest. Furthering our understanding of the complex osteoimmune cell interactions should provide new avenues of therapeutic intervention for RA.
登录
查看更多内容
DOI:
10.1084/jem.20092210
发表时间:
2010-05-10
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Allende ML;Tuymetova G;Lee BG;Bonifacino E;Wu YP;Proia RL
通讯作者:
Proia RL
影响因子:
4.9
作者:
Cavanagh LL;Boyce A;Smith L;Padmanabha J;Filgueira L;Pietschmann P;Thomas R
通讯作者:
Thomas R
DOI:
10.1084/jem.190.12.1741
发表时间:
1999-12-20
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Arai F;Miyamoto T;Ohneda O;Inada T;Sudo T;Brasel K;Miyata T;Anderson DM;Suda T
通讯作者:
Suda T
影响因子:
4.9
作者:
Adamopoulos IE;Chao CC;Geissler R;Laface D;Blumenschein W;Iwakura Y;McClanahan T;Bowman EP
通讯作者:
Bowman EP
影响因子:
--
作者:
AKAHOSHI, T;WADA, C;MATSUSHIMA, K
通讯作者:
MATSUSHIMA, K